Chemical Biology Program

The Yael David Lab

Research

Yael David
Yael David, PhD

Research efforts in the David lab apply core techniques in chemical biology, biochemistry, and cell biology to address fundamental questions in the epigenetic regulation of transcription. Epigenetic regulation relies on the dynamic modification of the two building blocks of chromatin: DNA and histone packaging proteins, to establish and maintain cell identity and fate. We develop and utilize chemical methods to synthesize site-specifically modified histones in vitro and in vivo and study the roles that these modifications play in disease states, with the ultimate goal of targeting them for therapeutics.

View The Yael David Lab Website

View Lab Overview

Publications Highlights

Prescott NA, Mansisidor A, Bram Y, Lemmon AA, Lim C, Risca VI, Schwartz RE, David Y. A nucleosome switch primes Hepatitis B Virus infection, bioRxiv https://doi.org/10.1101/2023.03.03.531011. Cell,. in press.

Zheng Q, Bastle RM, Zhao S, Kong L, Vostal L, Ramakrishnan A, Shen L, Fulton SL, Wang H, Zhang B, Upad A, Dierdorff L, Thompson RE, Molina H, Stransky S, Sidoli S, Muir TW, Li H, David Y#, Maze I#. Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity. bioRxiv https://doi.org/10.1101/2022.12.06.519310. Nature.. 2025 Jan;637(8047):974-982. doi: 10.1038/s41586-024-08371-3. Epub 2025 Jan 8. PMID: 39779849

Agustinus A,…David Y#, Bakhoum S#. Epigenetic dysregulation from chromosomal transit in micronuclei. Nature. 2023 Jul;619(7968):176-183. doi: 10.1038/s41586-023-06084-7. Epub 2023 Jun 7

Zheng Q, Omans ND, Leicher R, Osunsade A, Agustinus AS, Finkin-Groner E, D’Ambrosio H, Liu B, Chandarlapaty S, Liu S, David Y. Reversible histone glycation is associated with disease-related changes in chromatin architecture. Nat Commun. 2019 Mar 20;10(1):1289. doi: 10.1038/s41467-019-09192-z

Osunsade A, Prescott NA, Hebert JM, Ray DM and David Y. A Robust Method for the Purification and Characterization of the Human Histone H1 Variants. Biochemistry. 2018 Dec 26. doi: 10.1021/acs.biochem.8b01060.

View All Publications

People

Yael David

Yael David, PhD

  • Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.
  • Ph.D – The Weizmann Institute of Science
  • B.Sc SUNY Stony Brook
davidshy@mskcc.org
Email Address
646-888-2127
Office Phone
Download CV
PDF File

Members

Yael David
Assistant Member
WCM Pharmacology Graduate Student
Administrative Assistant
TPCB Graduate student
TPCB Graduate student
Research Assistant
Albert Agustinus, Research Technician
Research Technician
Ifeh Akano
WCM Pharmacology Graduate Student
Research Fellow
Efrat Finkin, Research Associate
Research Associate
Jakob Hebert, TPCB Graduate Student
TPCB Graduate Student
Igor  Maksimovic
TPCB Graduate Student
Nathaniel Omans, Graduate Student
Rotation Student
Adewola Osunsade, TPCB Graduate Student
TPCB Graduate Student
Rasmus Pihl
Research Fellow
Nicholas Prescott, Graduate Student
TPCB Graduate Student
Devin Ray
TPCB Graduate Student
Research Technician
Qingfei Zheng, Research Fellow
Research Fellow

Achievements

  • Josie Robertson Investigator (2016-2021)
  • Pershing Square Sohn Cancer Alliance Award
  • Experimental Therapeutic Discovery Center grant
  • Specialized Program of Research Excellence (SPORE) Award
  • CEBRA award
  • Parker Institute for Cancer Immunotherapy Award
  • Star Cancer Consortium grant
  • The Center for Educational Resources Project Collaborative Grant
  • National Institute of General Medical Sciences grant

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Graduate Students & Post-Doctoral Fellows

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Yael David discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures